Cost-effectiveness of vector control for supplementing mass drug administration for eliminating lymphatic filariasis in India

Donald S. Shepard,Aung K. Lwin,Sunish I. Pulikkottil,Mariapillai Kalimuthu,Natarajan Arunachalam,Brij K. Tyagi,Graham B. White

DOI: https://doi.org/10.1371/journal.pntd.0011835

2024-12-06

PLoS Neglected Tropical Diseases

Abstract:Despite progress using mass drug administration (MDA), lymphatic filariasis (LF) remains a major public health issue in India. Vector control could potentially augment MDA towards LF elimination. We conducted a cost-effectiveness analysis of MDA alone and MDA together with vector control single (VCS) modality or vector control integrated (VCI) modalities. Data came from historical controls and a three-arm cluster randomized trial of 36 villages at risk of LF transmission in Tamil Nadu, India. The arms were: MDA alone (the standard of care); MDA plus VCS (expanded polystyrene beads covering the water surface in wells and cesspits to suppress the filariasis vector mosquito Culex quinquefasciatus ); and MDA plus VCI (VCS plus insecticidal pyrethroid-impregnated curtains [over windows, doors, and eaves). Economic costs in 2010 US 0.53 for MDA alone, US 1.83 for VCI. With MDA offered in all arms, all arms reduced LF prevalence substantially from 2010 to 2013. MDA proved highly cost effective at $112 per DALY averted, a very small (8%) share of India's then per capita Gross Domestic Product. Progress towards elimination was comparable across all three study arms. The well-functioning MDA program proved effective and very cost-effective for eliminating LF, leaving little scope for further improvement. Supplementary vector control demonstrated no statistically significant additional benefit on MfP or AgP in this trial. Lymphatic filariasis (LF) is one of the twenty neglected tropical diseases (NTDs) that affect more than one billion people worldwide. Aligned with global initiatives to eliminate LF, India initiated Mass Drug Administration (MDA) trials in limited population groups in the 1980s. Since 2004, the Indian government has implemented repeated MDA campaigns to further this goal. Despite these efforts, LF has not yet been eliminated. Although vector control (VC) is proposed to augment regular MDA to help eliminate LF, little is known about the increased impact or costs. Our study compares the costs of MDA alone to the combination of MDA with alternative VC interventions. For each intervention, we calculated both program operating costs and costs to communities. We found MDA to be very effective (better than initially expected) and cost-effective for eliminating LF. However, against the low endemicity at the study site in the study's final year from MDA alone, the study had limited ability to detect any possible further reductions in MfP or AgP. We found no significant incremental improvements from VC in our study's setting compared to MDA.

tropical medicine,parasitology